Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1999; 81(03): 476-477
DOI: 10.1055/s-0037-1614507
DOI: 10.1055/s-0037-1614507
Letters to the Editor
Parvovirus B19 DNA Contamination in Coagulation Factor VIII Products
Authors
Further Information
Publication History
Publication Date:
09 December 2017 (online)
-
References
- 1 EiS-Hübinger AM, Sasowski U, Brackmann HH, Kaiser R, Matz B, Schneweis KE. Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products. Thromb Haemost 1996; 76: 1120.
- 2 Saldanha J, Minor P. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture. Br J Haematol 1996; 93: 714-9.
- 3 Lefrère JJ, Mariotti M, Thauvin M. B19 parvovirus DNA in solvent/detergent-treated antihaemophilia concentrates. The Lancet 1994; 343: 211-2.
- 4 Zakrzewska K, Azzi A, Patou G, Morfini M, Rafanelli D, Pattison JR. Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992; 81: 407-12.
- 5 McOmish F, Yap PL, Jordan A, Hart H, Cohen BJ, Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993; 31: 323-8.
- 6 Durigon EL, Erdman DD, Gary GW, Pallansch MA, Torok TJ, Anderson LJ. Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods 1993; 44: 155-65.
- 7 Hart HF, Hart WG, Crossley J, Perrie AM, Wood DJ, John A, McOmish F. Effect of terminal (dry) heat treatment on nonenveloped viruses in coagulation factor concentrates. Vox Sang 1994; 67: 345-50.